Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Ritonavir CAS 155213-67-5 Suppliers and Manufacturers for Pharmaceutical Production

Dec . 03, 2024 17:12 Back to list

Ritonavir CAS 155213-67-5 Suppliers and Manufacturers for Pharmaceutical Production



Ritonavir An Overview of CAS No. 155213-67-5 and Its Manufacturers


Ritonavir, a protease inhibitor, is an essential antiviral medication primarily used in the treatment of HIV/AIDS. Its designation as CAS No. 155213-67-5 is an identifier that provides detailed information regarding its chemical structure and properties. This medication plays a pivotal role in antiretroviral therapy, both in its standalone form and as part of combination therapies. Understanding the manufacturing landscape of Ritonavir is crucial for pharmaceutical companies, healthcare providers, and patients alike.


The Importance of Ritonavir


Ritonavir was initially developed in the early 1990s and became one of the first drugs to demonstrate significant effectiveness in reducing viral load in people living with HIV. It works by inhibiting the protease enzyme that HIV requires to replicate. By blocking this enzyme, Ritonavir prevents the virus from maturing and multiplying, thus slowing the progression of the disease. Over the years, Ritonavir has also been utilized in lower doses as a booster for other protease inhibitors, enhancing their bioavailability and effectiveness.


As a member of the antiretroviral drug class, Ritonavir has been crucial in the global fight against HIV/AIDS, particularly in resource-limited settings. Its use, alongside other antiretroviral drugs, has transformed HIV from a fatal disease into a manageable chronic condition for many patients. The robust clinical data supporting the use of Ritonavir has made it a staple in HIV treatment protocols worldwide.


Manufacturers of Ritonavir


The manufacturing of Ritonavir falls under stringent regulations and standards to ensure the safety and efficacy of the drug. Various pharmaceutical companies around the globe have ventured into the production of Ritonavir, ranging from large multinational corporations to specialized generic drug manufacturers.


Major Pharmaceutical Companies


ritonavir cas 155213-67-5 manufacturers

ritonavir cas 155213-67-5 manufacturers

1. AbbVie Originally developed by Abbott Laboratories, Ritonavir was brought to market under the brand name Norvir. AbbVie continues to produce and distribute Ritonavir, ensuring that the drug remains accessible in various formulations, including tablets and capsules. Their commitment to research and development has also led to advancements in combination therapies featuring Ritonavir.


2. Teva Pharmaceutical Industries As a leading generic manufacturer, Teva has developed its own version of Ritonavir. The company's ability to produce high-quality generics has allowed for broader access to essential medications, including Ritonavir, especially in markets where affordability is a significant concern.


3. Mylan Mylan, another major player in the generic pharmaceutical industry, recognizes the demand for Ritonavir globally. They offer Ritonavir in various formulations, focusing on meeting international health standards and contributing to public health objectives.


4. Sun Pharmaceutical Industries This Indian company has also entered the market for Ritonavir, providing quality generic options. Sun Pharma employs rigorous quality control measures to ensure the consistency and safety of their products, making them a trusted manufacturer in the HIV treatment landscape.


Conclusion


Ritonavir, with its CAS No. 155213-67-5, remains an integral component of HIV/AIDS treatment regimens. The collaborative efforts of major manufacturers ensure that patients worldwide can access this life-saving medication. As research continues and treatment methods evolve, the role of Ritonavir may expand further, solidifying its place in modern medicine. The ongoing commitment to quality manufacturing and accessibility will be crucial in maintaining the effectiveness of Ritonavir as a frontline therapy against HIV/AIDS, ultimately contributing to the goal of ending the epidemic.


In essence, the story of Ritonavir exemplifies the intersection of pharmacology, manufacturing, and the global health landscape, highlighting the importance of access to effective medications in the fight against infectious diseases.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish